Every filing, one decision per row.

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Companies 1/25
Result 613 decisions over 120 months
Reset filters
Minimum amount ? Share of their own holding ?
What the chief executive holds ?
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
16 Jan 2018
CVP, THV Replacement
Sold, plan not stated
6,300
$762.30K
5.4%
4 Jan 2018
Chairman & CEO
Sold, plan not stated
32,800
$3.77M
44.2%
28 Dec 2017
CVP,Strategy/Corp Development
Sold, plan not stated
5,300
$604.61K
21.3%
19 Dec 2017
Chairman & CEO
Sold, plan not stated
32,800
$3.77M
44.2%
15 Dec 2017
CVP, THV Replacement
Sold, plan not stated
18,960
$2.17M
14.7%
29 Nov 2017
CVP,Strategy/Corp Development
Sold, plan not stated
5,300
$617.18K
21.3%
20 Nov 2017
Chairman & CEO
Sold, plan not stated
32,900
$3.52M
44.3%
15 Nov 2017
CVP, THV Replacement
Sold, plan not stated
18,960
$1.99M
14.7%
9 Nov 2017
Director indirect
Sold, plan not stated
1,000
$104.15K
2.5%
30 Oct 2017
Chairman & CEO
Sold, plan not stated
32,900
$3.32M
44.3%
30 Oct 2017
CVP, Heart Valve Therapy
Sold, plan not stated
5,300
$535.92K
21.3%
16 Oct 2017
CVP, THV Replacement
Sold, plan not stated
18,960
$2.06M
14.7%
29 Sep 2017
CVP, Heart Valve Therapy
Sold, plan not stated
5,300
$576.97K
21.3%
15 Sep 2017
CVP, THV Replacement
Sold, plan not stated
18,960
$2.13M
14.7%
7 Sep 2017
Chairman & CEO
Sold, plan not stated
32,900
$3.70M
44.3%
30 Aug 2017
CVP, THV Replacement
Sold, plan not stated
18,960
$2.12M
14.7%
29 Aug 2017
CVP, Heart Valve Therapy
Sold, plan not stated
5,300
$594.40K
21.3%
9 Aug 2017
Chairman & CEO
Sold, plan not stated
32,900
$3.82M
34.3%
4 Aug 2017
CVP, Heart Valve Therapy
Sold, plan not stated
25,000
$2.90M
56.0%
31 Jul 2017
Chairman & CEO
Sold, plan not stated
32,900
$3.78M
34.3%
31 Jul 2017
CVP, Critical Care & Vascular
Sold, plan not stated
4,681
$541.97K
12.0%
28 Jul 2017
CVP, Heart Valve Therapy
Sold, plan not stated
5,300
$607.78K
5.9%
29 Jun 2017
CVP, Heart Valve Therapy
Sold, plan not stated
5,600
$656.03K
6.2%
29 Jun 2017
CVP, Critical Care & Vascular
Sold, plan not stated
4,716
$557.01K
10.8%
7 Jun 2017
Chairman & CEO
Sold, plan not stated
32,900
$3.88M
34.3%
31 May 2017
CVP, Europe
Sold, plan not stated
10,000
$1.15M
7.2%
19 May 2017
CVP, Europe
Sold, plan not stated
10,000
$1.13M
7.2%
17 May 2017
CVP, Europe
Sold, plan not stated
12,631
$1.43M
8.9%
15 May 2017
CVP, Europe
Sold, plan not stated
4,500
$509.10K
3.3%
12 May 2017
CVP, Europe
Sold, plan not stated
7,000
$774.73K
4.8%
8 May 2017
CVP, Heart Valve Therapy
Sold, plan not stated
9,100
$1.00M
10.6%
5 May 2017
CVP, Heart Valve Therapy
Sold, plan not stated
10,000
$1.10M
11.5%
4 May 2017
CVP, Heart Valve Therapy
Sold, plan not stated
10,000
$1.10M
11.5%
3 May 2017
Chairman & CEO
Sold, plan not stated
49,100
$5.39M
62.1%
3 May 2017
CVP, Heart Valve Therapy
Sold, plan not stated
14,120
$1.55M
15.5%
2 May 2017
CVP, Heart Valve Therapy
Sold, plan not stated
10,000
$1.10M
12.2%
28 Apr 2017
Chairman & CEO
Sold, plan not stated
49,100
$5.39M
62.1%
27 Apr 2017
CVP, Europe
Sold, plan not stated
24,000
$2.62M
15.7%
27 Apr 2017
CVP, Surgical Heart Valves
Sold, plan not stated
18,050
$1.97M
65.4%
27 Apr 2017
VP, Corporate Controller
Sold, plan not stated
12,960
$1.42M
43.3%
5 Apr 2017
CVP, Heart Valve Therapy
Sold, plan not stated
13,720
$1.28M
16.0%
30 Mar 2017
CVP, Europe
Sold, plan not stated
24,000
$2.25M
15.7%
15 Mar 2017
Chairman & CEO
Sold, plan not stated
49,100
$4.62M
61.6%
6 Mar 2017
CVP, Heart Valve Therapy
Sold, plan not stated
13,720
$1.23M
17.0%
16 Feb 2017
Chairman & CEO
Sold, plan not stated
49,100
$4.40M
61.6%
6 Feb 2017
CVP, Heart Valve Therapy
Sold, plan not stated
13,720
$1.23M
18.1%
3 Feb 2017
Director indirect
Bought
3,000
$270.30K
49.7%
13 Jan 2017
Chairman & CEO
Sold, plan not stated
49,100
$4.77M
61.6%
12 Jan 2017
CVP, Heart Valve Therapy
Sold, plan not stated
13,720
$1.34M
19.4%
19 Dec 2016
Chairman & CEO
Sold, plan not stated
49,100
$4.52M
61.6%
Showing 551–600 of 613. ← Newer Page 12 of 13 Older →